207 related articles for article (PubMed ID: 31126271)
1. Factors affecting survival in patients with endobronchial malignant mass after flexible Bronchoscopic cryotherapy: a cohort study.
Chung FT; Chou CL; Lo YL; Kuo CH; Wang TY; Wang CH; Huang HY; Lin HC; Chang CH; Lee CS; Chen HC; Lin SM
BMC Pulm Med; 2019 May; 19(1):101. PubMed ID: 31126271
[TBL] [Abstract][Full Text] [Related]
2. Removal of endobronchial malignant mass by cryotherapy improved performance status to receive chemotherapy.
Fang YF; Hsieh MH; Wang TY; Lin HC; Yu CT; Chou CL; Lin SM; Kuo CH; Chung FT
ScientificWorldJournal; 2014; 2014():369739. PubMed ID: 25383370
[TBL] [Abstract][Full Text] [Related]
3. Role of flexible bronchoscopic cryotechnology in diagnosing endobronchial masses.
Chou CL; Wang CW; Lin SM; Fang YF; Yu CT; Chen HC; Kuo CH; Hsieh MH; Chung FT
Ann Thorac Surg; 2013 Mar; 95(3):982-6. PubMed ID: 23352294
[TBL] [Abstract][Full Text] [Related]
4. The impact of superior mediastinal lymph node metastases on prognosis in non-small cell lung cancer located in the right middle lobe.
Sakao Y; Okumura S; Mingyon M; Uehara H; Ishikawa Y; Nakagawa K
J Thorac Oncol; 2011 Mar; 6(3):494-9. PubMed ID: 21266920
[TBL] [Abstract][Full Text] [Related]
5. Bronchoscopic findings and bleeding control predict survival in patients with solid malignancies presenting with mild hemoptysis.
Grosu HB; Casal RF; Morice RC; Nogueras-González GM; Eapen GA; Ost D; Sarkiss MG; Jimenez CA
Ann Am Thorac Soc; 2013 Aug; 10(4):342-9. PubMed ID: 23952853
[TBL] [Abstract][Full Text] [Related]
6. Lung cancer chemotherapy. Response-survival relationship depends on the method of chest tumor response evaluation.
Pujol JL; Parrat E; Lehmann M; Gautier V; Daurès JP; Michel FB; Godard P
Am J Respir Crit Care Med; 1996 Jan; 153(1):243-9. PubMed ID: 8542123
[TBL] [Abstract][Full Text] [Related]
7. Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study.
Bradley JD; Paulus R; Komaki R; Masters G; Blumenschein G; Schild S; Bogart J; Hu C; Forster K; Magliocco A; Kavadi V; Garces YI; Narayan S; Iyengar P; Robinson C; Wynn RB; Koprowski C; Meng J; Beitler J; Gaur R; Curran W; Choy H
Lancet Oncol; 2015 Feb; 16(2):187-99. PubMed ID: 25601342
[TBL] [Abstract][Full Text] [Related]
8. Impact of systematic EGFR and KRAS mutation evaluation on progression-free survival and overall survival in patients with advanced non-small-cell lung cancer treated by erlotinib in a French prospective cohort (ERMETIC project--part 2).
Cadranel J; Mauguen A; Faller M; Zalcman G; Buisine MP; Westeel V; Longchampt E; Wislez M; Coudert B; Daniel C; Chetaille B; Michiels S; Blons H; Solassol J; De Fraipont F; Foucher P; Urban T; Lacroix L; Poulot V; Quoix E; Antoine M; Danton G; Morin F; Chouaid C; Pignon JP
J Thorac Oncol; 2012 Oct; 7(10):1490-502. PubMed ID: 22982650
[TBL] [Abstract][Full Text] [Related]
9. Predictive factors of gefitinib antitumor activity in East Asian advanced non-small cell lung cancer patients.
Chang GC; Tsai CM; Chen KC; Yu CJ; Shih JY; Yang TY; Lin CP; Hsu JY; Chiu CH; Perng RP; Yang PC; Yang CH
J Thorac Oncol; 2006 Jul; 1(6):520-5. PubMed ID: 17409911
[TBL] [Abstract][Full Text] [Related]
10. Comparison of outcomes for patients with unresectable, locally advanced non-small-cell lung cancer treated with induction chemotherapy followed by concurrent chemoradiation vs. concurrent chemoradiation alone.
Huang EH; Liao Z; Cox JD; Guerrero TM; Chang JY; Jeter M; Borghero Y; Wei X; Fossella F; Herbst RS; Blumenschein GR; Moran C; Allen PK; Komaki R
Int J Radiat Oncol Biol Phys; 2007 Jul; 68(3):779-85. PubMed ID: 17418967
[TBL] [Abstract][Full Text] [Related]
11. The insertion of self expanding metal stents with flexible bronchoscopy under sedation for malignant tracheobronchial stenosis: a single-center retrospective analysis.
McGrath EE; Warriner D; Anderson P
Arch Bronconeumol; 2012 Feb; 48(2):43-8. PubMed ID: 22137422
[TBL] [Abstract][Full Text] [Related]
12. Wedge resection of the bronchus: an alternative bronchoplastic technique for preservation of lung tissue.
Kotoulas C; Lazopoulos G; Foroulis C; Konstantinou M; Tomos P; Lioulias A
Eur J Cardiothorac Surg; 2001 Oct; 20(4):679-83. PubMed ID: 11574207
[TBL] [Abstract][Full Text] [Related]
13. Location Matters: Stage I Non-Small-cell Carcinomas of the Lower Lobes Treated With Stereotactic Body Radiation Therapy Are Associated With Poor Outcomes.
Shaverdian N; Veruttipong D; Wang J; Kupelian P; Steinberg M; Lee P
Clin Lung Cancer; 2017 Mar; 18(2):e137-e142. PubMed ID: 27908620
[TBL] [Abstract][Full Text] [Related]
14. Prognostic factors associated with interventional bronchoscopy in lung cancer.
Guibert N; Mazieres J; Lepage B; Plat G; Didier A; Hermant C
Ann Thorac Surg; 2014 Jan; 97(1):253-9. PubMed ID: 24094520
[TBL] [Abstract][Full Text] [Related]
15. Improvement in population-based survival of stage IV NSCLC due to increased use of chemotherapy.
Aarts MJ; van den Borne BE; Biesma B; Kloover JS; Aerts JG; Lemmens VE
Int J Cancer; 2015 Mar; 136(5):E387-95. PubMed ID: 25219898
[TBL] [Abstract][Full Text] [Related]
16. Resection of giant endobronchial hamartoma by electrocautery and cryotherapy via flexible bronchoscopy.
Altin S; Dalar L; Karasulu L; Cetinkaya E; Timur S; Solmazer N
Tuberk Toraks; 2007; 55(4):390-4. PubMed ID: 18224508
[TBL] [Abstract][Full Text] [Related]
17. Survival after photodynamic therapy to non-pulmonary metastatic endobronchial tumors.
McCaughan JS
Lasers Surg Med; 1999; 24(3):194-201. PubMed ID: 10229150
[TBL] [Abstract][Full Text] [Related]
18. Restoration of Patency to Central Airways Occluded by Malignant Endobronchial Tumors Using Intratumoral Injection of Cisplatin.
Mehta HJ; Begnaud A; Penley AM; Wynne J; Malhotra P; Fernandez-Bussy S; Cope J; Shuster JJ; Jantz MA
Ann Am Thorac Soc; 2015 Sep; 12(9):1345-50. PubMed ID: 26072968
[TBL] [Abstract][Full Text] [Related]
19. Surgical results of metastatic spinal cord compression (MSCC) from non-small cell lung cancer (NSCLC): analysis of functional outcome, survival time, and complication.
Park SJ; Lee CS; Chung SS
Spine J; 2016 Mar; 16(3):322-8. PubMed ID: 26586194
[TBL] [Abstract][Full Text] [Related]
20. Phase II trial of induction high-dose chemotherapy followed by surgical resection and radiation therapy for patients with marginally resectable non-small cell carcinoma of the lung.
Schilder RJ; Goldberg M; Millenson MM; Movsas B; Rogatko A; Rogers B; Langer CJ
Lung Cancer; 2000 Jan; 27(1):37-45. PubMed ID: 10672782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
